Jakub Rohlena

13PUBLICATIONS

54CO-AUTHORS

HaematologyMolecular targetsClinical midwiferyCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|May 06, 2026

HSPCs and Treg cells cooperate to preserve extramedullary hematopoiesis under chronic inflammation.

|May 07, 2025

Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention.

Klara Bohacova, Zuzana Nahacka, Jana Dudova

|Jan 30, 2024

Mitochondrial HER2 stimulates respiration and promotes tumorigenicity.

Eliska Novotna, Mirko Milosevic, Dana Prukova

|Jan 11, 2024

Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners.

Pankaj Sharma, Elena Maklashina, Markus Voehler

|Sep 28, 2023

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126.

Jiri Neuzil, Jakub Rohlena, Lukas Werner

|Feb 16, 2023

Mitochondria on the move: Horizontal mitochondrial transfer in disease and health.

Lan-Feng Dong, Jakub Rohlena, Renata Zobalova

Pageof 3

Frequent Collaborators

7 joint publications

Jiri Neuzil

3 joint publications

Sona Stemberkova Hubackova

Zuzana Nahacka

Stepana Boukalova

Tomas Mracek

Karel Pacak

Cyril Barinka

Katerina Rohlenova

Renata Zobalova

Meritxell Alberich-Jorda

Frequent Collaborators

7 joint publications

Jiri Neuzil

3 joint publications

Sona Stemberkova Hubackova

3 joint publications

Zuzana Nahacka

3 joint publications

Stepana Boukalova